Importance And Objective: Frailty refers to the decline in physiological reserve capacity caused by the deterioration of multiple physiological systems (brain, endocrine system, immune system, and skeletal muscle), leading to increased vulnerability and decreased stress capacity. Women have a higher prevalence of frailty than men, although the epidemiological factors underlying this phenomenon are not fully understood. Menopause and menopause-related characteristics may be among the contributing factors. Hence, the purpose of this scoping review was to explore the relationship between menopause and frailty. We attempted to summarize information such as the age that menopause occurs, years since menopause, types of menopause, and hormones and inflammatory markers of frailty among postmenopausal women.

Methods: PubMed, EMBASE, The Cochrane Library, the Cumulative Index to Nursing and Allied Health Literature and Web of Science, the China National Knowledge Infrastructure, the China Biomedical Literature Service System, Wanfang Database and the WeiPu (VIP) Database were searched from inception until April 3, 2019. Supplementary searches of the references, cited documents, and similar documents of the included literature were also carried out.

Discussion And Conclusions: Of 762 papers identified, 15 articles matching the criteria were included. The prevalence of frailty among postmenopausal women ranged from 5.9% to 57.3%. Existing studies suggest that menopause is associated with frailty. Early menopause, hysterectomy, low-free testosterone levels, and high C-reactive protein levels may increase the likelihood of frailty among postmenopausal women. Few original studies have explored the relationship between estrogen and frailty and the results of these studies are conflicting. Changes in hormone and inflammatory cytokine levels may mediate frailty among postmenopausal women. More in-depth research would be required to better understand the physiological and etiological mechanisms of the occurrence of frailty among postmenopausal women.

Download full-text PDF

Source
http://dx.doi.org/10.1097/GME.0000000000001612DOI Listing

Publication Analysis

Top Keywords

frailty postmenopausal
20
postmenopausal women
16
frailty
10
menopause
8
menopause frailty
8
scoping review
8
prevalence frailty
8
women
5
postmenopausal
5
frailty scoping
4

Similar Publications

Purpose: Hormone therapy (HT) is safe and effective in reducing breast cancer (BC) relapse rates and increasing disease-free periods. However, its various adverse physical and psychological effects could affect women's quality of life. These could be improved through a multimodal programme including physical exercise and health education.

View Article and Find Full Text PDF
Article Synopsis
  • - Type 2 diabetes mellitus (DM) is linked to increased risks of sarcopenia (muscle loss) and has a complex relationship with osteoporosis (OP) in postmenopausal women, highlighting the need for further study on these connections.
  • - A study involving 444 postmenopausal women found that those with DM had higher rates of sarcopenia (23.4%) and lower rates of OP (33.5%) compared to controls, suggesting differing impacts of DM on muscle and bone health.
  • - Results indicated that longer menopause duration positively influenced OP risk, while higher age and body mass index correlated with greater sarcopenia risk; DM appeared to negatively impact OLST scores, reflecting challenges
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the impact of a physical exercise and health education program on metabolic syndrome (MS) and quality of life (QoL) in postmenopausal women with breast cancer who are undergoing treatment with aromatase inhibitors.
  • - Results showed a significant reduction in the prevalence of MS from 37.7% to 15.1% after three months, with notable improvements in hypertension, central obesity, and triglyceride levels, while fasting glucose and HDL levels remained unchanged.
  • - Improvements in QoL were statistically significant, and factors such as being married and attending health education sessions positively predicted better MS outcomes.
View Article and Find Full Text PDF

Association of premature natural and surgical menopause with incidence of depression requiring hospitalization: a prospective cohort study.

Am J Obstet Gynecol

November 2024

Department of Social Medicine and Health Management, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Electronic address:

Background: Premature menopause is associated with depression in postmenopausal women. However, current evidence ignores the differences between premature natural and surgical menopause, and there is a lack of exploration of the mechanisms underlying the association between premature menopause and depression.

Objective: To examine the association of premature natural and surgical menopause with incidence of depression requiring hospitalization, and to evaluate whether frailty and menopausal hormone therapy are significant factors contributing to a higher incidence of depression requiring hospitalization associated with premature natural and surgical menopause, in comparison to women who experience menopause after age 40.

View Article and Find Full Text PDF

Musculoskeletal Failure.

Am J Lifestyle Med

May 2024

Lore, Yardley, PA, USA (BW).

Osteoarthritis, osteoporosis, and sarcopenia are prevalent musculoskeletal disorders that significantly impact the aging population's health and quality of life. Osteoarthritis, characterized by joint inflammation, leads to pain, stiffness, and reduced mobility. Osteoporosis, a condition marked by bone density loss, increases fracture susceptibility, especially in postmenopausal women and older adults.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!